Caspar E.P. van Munster

Statistics

Publications

Citations

188

H-Index

Active since

2008

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Amsterdam Neuroscience

University College London

Sanquin

Alrijne Ziekenhuis

Caspar E.P. van Munster is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in multiple sclerosis, neurology, and pharmacotherapy.

ORCID

Publications per year

2008–2024

Publications

An observational study of alemtuzumab following fingolimod for multiple sclerosis

Mark Willis, Owen Pearson, Zsolt Illés et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 59 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Differences in Aneurysm and Patient Characteristics Between Cohorts of Finnish and Dutch Patients With Subarachnoid Hemorrhage

Caspar E.P. van Munster, Mikael von und zu Fraunberg, Gabriël J.E. Rinkel et al. · Stroke · 2008 · 29 citations

Medicine, Neurosurgery, Surgery +11

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis

Eline M. E. Coerver, Wing Hee Fung, Janet de Beukelaar et al. · JAMA Neurology · 2024 · 27 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Disease activity following pregnancy-related discontinuation of natalizumab in MS

Iris Kleerekooper, Zoé L. E. van Kempen, Cyra E Leurs et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 18 citations · Full text

Medicine, Pharmacotherapy, Maternal-fetal Medicine +9

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

Alyssa A Toorop, Zoë YGJ van Lierop, Liza M. Y. Gelissen et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

1–5 of 8